Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

PURPOSE: This study aimed to compare the efficacy and safety of generic and branded irbesartan for 8 weeks in patients with mild-to-moderate essential hypertension. PATIENTS AND METHODS: We screened 221 patients with mild-to-moderate hypertension. After exclusion per study criteria, 177 subjects wer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Des Devel Ther
Autors principals: Han, Seung Hwan, Oh, Gyu Chul, Kwon, Hyuck Moon, Park, Chang Gyu, Kim, In Jai, Hwang, Gyo-Seung, Yoo, Byung Su, Park, Seong Hoon, Lee, Kwang Je, Kim, Hyo-soo
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6304086/
https://ncbi.nlm.nih.gov/pubmed/30587918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S172046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars